Stocktoria

ALIGN TECHNOLOGY INC ALGN

Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2001-01-26 · LEI

ALIGN TECHNOLOGY INC (ALGN) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $4.0B at a 10.2% net margin.

Chart by TradingView
66/100
Stocktoria Quality Score · grade B
6/9
Piotroski F — financial health
4.56
Altman Z″ — distress risk · safe
Dividend yield · no dividend
-2.51
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
6 5 6 5 4 5 4 6 6 6 2016201720182019202020212022202320242025
Altman Z″
6.94 6.17 5.72 4.99 4.87 4.81 4.29 3.99 4.15 4.56 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$174.01 as of 2026-08-01 · +22.6% 1y
$125.22$190.1052-wk

Beneish M-score: -2.51 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$12.8B
P / E31.1×
Net margin 5y avg12.3%
Return on equity 5y avg12.9%
Beta1.65
Employees20,435

Analyst price target

$208.60 +19.9% vs last
consensus: buy · 15 analysts
target range $170.00 – $240.00 · median $209.00
2 strong buy · 8 buy · 6 hold · 1 strong sell
Recent analyst actions
DateFirmRating
2026-07-09BMO CapitalOutperform (init)
2026-04-30Evercore ISI GroupOutperform (main)
2026-04-24Morgan StanleyEqual-Weight (main)
2026-04-21Piper SandlerOverweight (main)
2026-04-15CitigroupBuy (init)
2026-03-17BarclaysOverweight (up)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$12.55
Forward P / E13.9×

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 78%
Net marginstronger than 79%
Return on equitystronger than 74%
Revenue growthstronger than 36%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 6/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.112
Retained earnings / assets0.395
EBIT / assets0.088
Equity / liabilities1.854

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
ALGNALIGN TECHNOLOGY INC6/94.5631.1+0.9%
ENOVEnovis CORP4/9-1.51+6.7%
STESTERIS plc9/94.526.9+8.7%
EWEdwards Lifesciences Corp6/99.648.7+11.5%
MSAMSA Safety Inc6/95.6523.6+3.7%
AVNSAVANOS MEDICAL, INC.5/91.17+1.9%
CDRECadre Holdings, Inc.6/93.727.2+7.5%

All Manufacturing companies →

About ALIGN TECHNOLOGY INC

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

FAQ

Is ALGN financially healthy?

ALIGN TECHNOLOGY INC's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does ALGN pay a dividend?

No, ALIGN TECHNOLOGY INC does not currently pay a dividend.

How profitable is ALGN?

In FY2025, ALIGN TECHNOLOGY INC had a net margin of 10.2% and a return on equity of 10.1%.

Is ALGN overvalued or undervalued?

ALIGN TECHNOLOGY INC trades at about 30.8× trailing earnings — below its 10-year norm (10-year range 23.4×–92.6×, median 46.5×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for ALGN?

The average Wall-Street price target for ALIGN TECHNOLOGY INC is $208.60, about 19.9% above the recent price, from 15 analysts (consensus: buy).

Is ALGN a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on ALIGN TECHNOLOGY INC: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 31.1×. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.